Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection

Christopher Bowd, Ali Tafreshi, Gianmarco Vizzeri, Linda M. Zangwill, Pamela A. Sample, Robert N. Weinreb

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA. STUDY DESIGN: In all, 70 eyes of 35 healthy individuals (intraocular pressure <22mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81?dB (SD=2.61). Methods: The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (μV) and phase (π rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots. Results: For healthy eyes, amplitude CVs (SD) were 11.5% (11.5) and 9.9% (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3% (1.5) (within-trials) and 1.5% (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2% (10.1) and 11.2% (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2% (2.2) (within-trials) and 2.4% (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes. Conclusions: Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.

Original languageEnglish (US)
Pages (from-to)437-443
Number of pages7
JournalJournal of Glaucoma
Volume18
Issue number6
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Glaucoma
Visual Fields
Electrodes
Optic Nerve Diseases
Visual Field Tests
Optic Disk
Intraocular Pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection. / Bowd, Christopher; Tafreshi, Ali; Vizzeri, Gianmarco; Zangwill, Linda M.; Sample, Pamela A.; Weinreb, Robert N.

In: Journal of Glaucoma, Vol. 18, No. 6, 08.2009, p. 437-443.

Research output: Contribution to journalArticle

Bowd, Christopher ; Tafreshi, Ali ; Vizzeri, Gianmarco ; Zangwill, Linda M. ; Sample, Pamela A. ; Weinreb, Robert N. / Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection. In: Journal of Glaucoma. 2009 ; Vol. 18, No. 6. pp. 437-443.
@article{e213dc0c022a493f93b5d21ef5b64a8a,
title = "Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection",
abstract = "Purpose: To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA. STUDY DESIGN: In all, 70 eyes of 35 healthy individuals (intraocular pressure <22mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81?dB (SD=2.61). Methods: The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (μV) and phase (π rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots. Results: For healthy eyes, amplitude CVs (SD) were 11.5{\%} (11.5) and 9.9{\%} (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3{\%} (1.5) (within-trials) and 1.5{\%} (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2{\%} (10.1) and 11.2{\%} (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2{\%} (2.2) (within-trials) and 2.4{\%} (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes. Conclusions: Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.",
author = "Christopher Bowd and Ali Tafreshi and Gianmarco Vizzeri and Zangwill, {Linda M.} and Sample, {Pamela A.} and Weinreb, {Robert N.}",
year = "2009",
month = "8",
doi = "10.1097/IJG.0b013e31818c6f44",
language = "English (US)",
volume = "18",
pages = "437--443",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection

AU - Bowd, Christopher

AU - Tafreshi, Ali

AU - Vizzeri, Gianmarco

AU - Zangwill, Linda M.

AU - Sample, Pamela A.

AU - Weinreb, Robert N.

PY - 2009/8

Y1 - 2009/8

N2 - Purpose: To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA. STUDY DESIGN: In all, 70 eyes of 35 healthy individuals (intraocular pressure <22mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81?dB (SD=2.61). Methods: The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (μV) and phase (π rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots. Results: For healthy eyes, amplitude CVs (SD) were 11.5% (11.5) and 9.9% (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3% (1.5) (within-trials) and 1.5% (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2% (10.1) and 11.2% (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2% (2.2) (within-trials) and 2.4% (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes. Conclusions: Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.

AB - Purpose: To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA. STUDY DESIGN: In all, 70 eyes of 35 healthy individuals (intraocular pressure <22mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81?dB (SD=2.61). Methods: The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (μV) and phase (π rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots. Results: For healthy eyes, amplitude CVs (SD) were 11.5% (11.5) and 9.9% (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3% (1.5) (within-trials) and 1.5% (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2% (10.1) and 11.2% (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2% (2.2) (within-trials) and 2.4% (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes. Conclusions: Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.

UR - http://www.scopus.com/inward/record.url?scp=70249115608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249115608&partnerID=8YFLogxK

U2 - 10.1097/IJG.0b013e31818c6f44

DO - 10.1097/IJG.0b013e31818c6f44

M3 - Article

VL - 18

SP - 437

EP - 443

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 6

ER -